Product Description
Introducing Hertraz 440, a splendiferous innovation employing recombinant DNA technology for the valuable management of HER2-positive breast cancer. Each imposing 440 mg vial is meticulously crafted for intravenous infusion, ensuring patients receive targeted anticancer treatment with precision. Supplied with 2 mL sterile water, this hospital-use prescription promises freshness and optimal potency. Explore a new standard for adult women-and select men-seeking hope against metastatic and early-stage breast cancer. Store in a cool, dry place for longevity. Promotion available for hospitals and institutions through certified distributors, exporters, suppliers, and wholesalers in India.
Comprehensive Features of Hertraz 440 Trastuzumab Injection
Used as an advanced anticancer therapy, Hertraz 440 is preferred by adult women (and select men) with HER2-positive breast cancer. Material features include recombinant DNA-origin Trastuzumab delivered as a multiple use vial combined with sterile water for precise dilution. This product is designed for intravenous infusion in clinical settings, offering personalized dosages as per prescription since its efficacy and safety depend on professional oversight.
Export and Supply Details with Competitive Offerings
Hertraz 440 is distributed globally, catering to major export markets throughout Asia, Africa, and beyond. We offer reliable delivery times and prompt quotations to meet institutional demands. Benefit from our competitive sale price, with freight options tailored to your requirements; products ship via major Indian FOB ports for efficiency. Partner with us for bulk supply, consistent quality, and splendiferous service ensuring your centers receive fresh, effective oncology solutions.
FAQ's of Trastuzumab injection:
Q: How is Hertraz 440 Trastuzumab administered to patients?
A: Hertraz 440 is administered as an intravenous (IV) infusion, which should be given only in a hospital or institutional setting under the supervision of qualified healthcare professionals.
Q: What makes Hertraz 440 valuable for HER2-positive breast cancer treatment?
A: Hertraz 440 targets the HER2 receptor, making it especially effective and valuable for patients with HER2-positive metastatic or early breast cancer. Its action specifically blocks the signals promoting cancer cell growth.
Q: When should a patient receive Hertraz 440 injections?
A: Hertraz 440 is used based on a physician's prescription, following confirmed diagnosis of HER2-positive breast cancer. The exact timing and dosing are determined by your oncologist according to your individual health profile.
Q: Where should Hertraz 440 be stored before use?
A: This medicine must be stored in a cool, dry place as indicated on the packaging to maintain its potency and safety. Always check the expiry date before usage.
Q: What is the process for preparing and infusing Hertraz 440?
A: Preparation involves diluting the contents of the vial with the supplied 2 mL sterile water. Medical professionals will then further dilute and administer it via IV infusion. Always allow trained staff to handle preparation and administration.
Q: What are the benefits of choosing Hertraz 440 for institutions?
A: Hertraz 440 offers a reliable, splendiferous solution for targeted breast cancer therapy with consistent quality, valuable export support, and prompt delivery for hospital and clinical needs.